Diagnostic and therapeutic considerations in patients with hypogammaglobulinemia after rituximab therapy.


PURPOSE OF REVIEW There are no established guidelines for evaluating and treating hypogammaglobulinemia in patients with rheumatic disease who receive B-cell depleting agents. The purpose of this article is to review findings in the work-up and treatment of common variable immunodeficiency (CVID) that can guide our evaluation of patients with autoimmune… (More)
DOI: 10.1097/BOR.0000000000000377


  • Presentations referencing similar topics